CONFERENCE SPEAKERS

Speakers
Melis McHenry
Melis McHenry
Associate Director, Precision Medicine CDx,
Regeneron


Alok Pandey
Alok Pandey
Vice President, Biomarker & Translational Science,
PBL Assay Science


Joseph Ferrara
Joseph Ferrara
Chief Strategy Officer,
Veranex


Samir Hanash
Samir Hanash
Director, McCombs Institute for Cancer Detection and Treatment,
MD Anderson Cancer Center


Vaibhav Saini
Vaibhav Saini
Senior Commercialization Manager,
Northeastern University


Ginette Serrero
Ginette Serrero
CEO, Precision Antibody,
A&G Pharmaceutical, Inc. | Precision Antibody

Dr. Ginette Serrero is Chief Executive Officer of Precision Antibody, a custom antibody development company, expert in the design, development, characterization and production of monoclonal antibodies for the treatment and diagnosis of human diseases. She draws on biotech management and research expertise in Oncology and biomarker discovery to guide the company's strategy in both the service division and R&D department for the development of biological targeted therapies with companion tissue and serum diagnostics for breast cancer. Her laboratory discovered Progranulin (GP88) as a marker of recurrence, drug resistance and tumor aggressiveness for several cancers including breast and lung cancer. This led to the development of two companion diagnostics that have been clinically validated for disease prognosis and monitoring of breast and lung cancer patients. She is a trained Biochemist with expertise in target discovery, Pharmaceutical Sciences and Oncology.  She is Adjunct Professor at the University of Maryland Greenebaum Comprehensive Cancer Center.

She is inventor on several worldwide patents for targets in Oncology and authored 100 peer-reviewed scientific publications and reviews.


Richard Dennis
Richard Dennis
Chief Commercial Officer,
Proteome Sciences

Richard is the CCO at Proteome Sciences and has over 30 years’ experience working in the proteomics and biotechnology sectors. Since joining Proteome Sciences in 2017 he has focused on leading the Company’s marketing and commercialisation strategy to offer clients a flexible, high quality service in our CRO business.


Russell Weiner
Russell Weiner
Head Oncology and Cell Therapy Clinical Biomarker Sciences,
Takeda


Ariel Lefkovith
Ariel Lefkovith
Manager, Biomarker Operations,
Repare Therapeutics


Ravinder Singh
Ravinder Singh
Professor of Laboratory Medicine and Pathology,
Mayo Clinic


Wenting Wang
Wenting Wang
Oncology Biomarker Statistics Team Lead,
Sanofi


Alexander Kuklin
Alexander Kuklin
Vice President CDx and BioPharma Partnerships,
Predicine


Mario Flores
Mario Flores
Assistant Professor, Department of Biomedical Engineering,
The University of Texas at San Antonio


Zheng Feng
Zheng Feng
Head, Molecular Biomarkers & Genomics,
EMD Serono


Amanda Acerbi
Amanda Acerbi
Precision Medicine Global Director,
Janssen


Althea Lang
Althea Lang
Scientific Project Manager, Translational Science,
Foundation for the National Institutes of Health


Bhaskarjyoti Sarmah
Bhaskarjyoti Sarmah
Associate Scientific Director, Clinical Biomarkers,
Moderna


Lindsay Darling
Lindsay Darling
Director, Companion Diagnostics Portfolio Management & Operations,
Regeneron


David Yu
David Yu
Director, Precision Medicine and Translational Medicine,
Bristol Myers Squibb


Yi-Ya Fang
Yi-Ya Fang
Senior advisor,
Eli Lilly and Company


Tyler Nielsen
Tyler Nielsen
Sr Scientist,
Oncocyte Corporation